← Research library

Chonluten in chronic bronchitis: Medical Center clinical report

Comparison in people · 2006

What was studied
42 adults aged 38–65 with chronic bronchitis and an asthmatic component: 23 received adjunctive Chonluten and 19 received conventional therapy.
Main finding
The report lists forced expiratory vital capacity of 3,800.8 mL after adjunctive Chonluten versus 3,200.7 mL after conventional care. It marks the former against a shared baseline of 2,850.6 mL.

Forced expiratory vital capacity · 3,800.8 ± 136.9 mL with Chonluten vs 3,200.7 ± 187.5 mL with conventional care. Shared baseline 2,850.6 ± 158.4 mL. · The Chonluten value is marked p < 0.05 versus baseline.

Reported findings and study design

23 patients received adjunctive Chonluten and 19 received conventional treatment. The methods give no tested regimen. The later recommendations list two different courses.

Population or model 42 adults aged 38–65 with chronic bronchitis and an asthmatic component: 23 received adjunctive Chonluten and 19 received conventional therapy.

Results · Medical Center report reproduced in the English compilation, PDF pages 123–125
MeasureResultComparison, timing and statistics
Forced expiratory vital capacity3,800.8 ± 136.9 mL with Chonluten vs 3,200.7 ± 187.5 mL with conventional care. Shared baseline 2,850.6 ± 158.4 mL.The Chonluten value is marked p < 0.05 versus baseline.
Vital capacity4,150.4 ± 265.6 mL with Chonluten vs 3,950.3 ± 298.12 mL with conventional care.The table gives no significance mark for this outcome.
Reported symptom improvement73% in the Chonluten group. The report gives no comparator percentage or prespecified response scale.

The spirometry comparison uses a shared baseline and supplies no between-group test.

Source for these results ↗ · Reviewed 2026-11-16

Study limitations and source details

Study limitations

  • The report gives one shared baseline and leaves allocation and masking unspecified.
  • The methods give no study dosing schedule. The recommendations list conflicting schedules.
  • The reported treatment course gives limited safety information and insufficient characterization to establish equivalence with synthetic EDG.

Source details

Institute report / commercial reproduction

Report reproduction, PDF pages 123–125. Population, symptom results and Table 1.

Sources checked

Citation

Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology

Human comparative studyFull text available

Originating institute; report reproduced in commercial collection. Chonluten in chronic bronchitis: Medical Center clinical report Reports on clinical studies of CYTOMAX and CYTOGEN products; PDF page 123

Study source ↗ · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards